Related Experiment Video
Updated: Aug 9, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Endocarditis after closure of ventricular septal defect by transcatheter device
Oded Scheuerman1, Elchanan Bruckheimer, Nufar Marcus
1Department of Pediatrics B, Schneider Children's Medical Center of Israel, Petah Tiqva, Israel. odedshv@clalit.org.il
Abstract:
Advances in interventional cardiology have enabled the treatment of severe congenital heart defects without the need for surgery. The percutaneous closure of atrial septal defects and, more recently, ventricular septal defects is considered a safe procedure with fewer complications and less morbidity compared with surgery. We report on a 2-year-old child who developed endocarditis after ventricular septal defect closure with an Amplatzer device. The patient recovered after intravenous antibiotics and anticoagulation. To the best of our knowledge, this is the first report of endocarditis associated with ventricular septal defect closure device insertion.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Endocarditis II: Clinical Features of Infective Endocarditis
Mitral Stenosis III: Medical Management
Aneurysm III: Interprofessional Care

